Womens Health Gaps

In this episode

The connection

For decades, medical researchers studied male lab mice almost exclusively, building human health baselines on just half the population. That blind spot left a massive gap in what medicine knows about female bodies. Jonquilyn Hill traces how this history of exclusion created a void that online influencers now exploit around perimenopause. Reading that next to Anissa Durham’s reporting brings the consequences straight into the modern exam room. Durham looks at a misunderstood metabolic condition, showing how racial bias and outdated science delay diagnoses for Black and Latina women. It is worth pausing on what happens when the medical establishment looks away, and who pays the price when patients are left to find answers themselves.

Jonquilyn Hill ends with a frustrating image: patients sitting in a doctor's office today, realizing the person in the white coat is still guessing about basic female biology. For decades, researchers treated women as small men, leaving entire medical fields playing catch-up. What jumps out reading Anissa Durham next is how that broad historical blind spot plays out in a specific hospital room. Durham looks at a condition recently renamed polyendocrine metabolic ovarian syndrome, or PMOS. Read alongside Hill, Durham’s reporting shows what happens when a baseline ignorance about female bodies collides with racial bias. Hill points out that doctors historically dismissed women’s pain as hysteria. Durham picks up that thread and shows how that dismissal mutates for Black and Latina women, who are often assumed to have a higher pain tolerance. The interesting thing is how the two pieces lock together. Hill explains why the medical system lacks data on women in general, while Durham reveals who pays the highest price for that missing information: patients like Bontle Moka-Moliki, who spent years waiting for someone to treat her daily pain as real.

A missing female lab mouse decades ago eventually becomes a misdiagnosed patient today. What lingers after hearing these stories is how an empty space in medical data turns into an active hazard. That void gets filled by online salespeople peddling quick fixes, or by clinical biases that send Black and Latina women home with no answers. The science is finally starting to catch up, replacing old assumptions with actual biology. But a harder question remains. How does a patient trust a medical clinic that is only just beginning to learn how her body works?